Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Top Cited Papers
Open Access
- 1 May 2018
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 102 (5), 575-585
- https://doi.org/10.1136/bjophthalmol-2017-311258
Abstract
Background Within a surveillance of the prevalence and causes of vision impairment in high-income regions and Central/Eastern Europe, we update figures through 2015 and forecast expected values in 2020. Methods Based on a systematic review of medical literature, prevalence of blindness, moderate and severe vision impairment (MSVI), mild vision impairment and presbyopia was estimated for 1990, 2010, 2015, and 2020. Results Age-standardised prevalence of blindness and MSVI for all ages decreased from 1990 to 2015 from 0.26% (0.10-0.46) to 0.15% (0.06-0.26) and from 1.74% (0.76-2.94) to 1.27% (0.55-2.17), respectively. In 2015, the number of individuals affected by blindness, MSVI and mild vision impairment ranged from 70 000, 630 000 and 610 000, respectively, in Australasia to 980 000, 7.46 million and 7.25 million, respectively, in North America and 1.16 million, 9.61 million and 9.47 million, respectively, in Western Europe. In 2015, cataract was the most common cause for blindness, followed by age-related macular degeneration (AMD), glaucoma, uncorrected refractive error, diabetic retinopathy and cornea-related disorders, with declining burden from cataract and AMD over time. Uncorrected refractive error was the leading cause of MSVI. Conclusions While continuing to advance control of cataract and AMD as the leading causes of blindness remains a high priority, overcoming barriers to uptake of refractive error services would address approximately half of the MSVI burden. New data on burden of presbyopia identify this entity as an important public health problem in this population. Additional research on better treatments, better implementation with existing tools and ongoing surveillance of the problem is needed.Keywords
Funding Information
- Brien Holden Vision Institute
This publication has 20 references indexed in Scilit:
- Long-Term Trends in Glaucoma-Related Blindness in Olmsted County, MinnesotaOphthalmology, 2013
- Age-related Prevalence and Met Need for Correctable and Uncorrectable Near Vision Impairment in a Multi-country StudyOphthalmology, 2013
- Global Prevalence of Vision Impairment and BlindnessOphthalmology, 2013
- Prevalence of Visual Impairment and Uncorrected Refractive Error – Report from a Canadian Urban Population-based StudyOphthalmic Epidemiology, 2013
- Prevalence and Associated Factors of Diabetic Retinopathy in Rural Central IndiaDiabetes Care, 2013
- New Systematic Review Methodology for Visual Impairment and Blindness for the 2010 Global Burden of Disease StudyOphthalmic Epidemiology, 2013
- Prevalence and Correction of Near Vision Impairment at Seven Sites in China, India, Nepal, Niger, South Africa, and the United StatesAmerican Journal of Ophthalmology, 2012
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2011
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006